Sign in to follow
Search Results

0 results for 'US Food and Drug Administration'

You can use to get even better search results
June 14, 2024 | Law.com

After Federal Judge's Dismissal, Zantac Legal Fight Reignites in State Courts

On May 23, the first verdict in the nation over Zantac came out in Illinois, while a Delaware judge's May 31 decision allowed plaintiffs' experts for thousands of cases.
7 minute read
June 14, 2024 | Connecticut Law Tribune

Dissecting the SCOTUS Mifepristone Decision: Don't Uncork the Bubbly Yet

I cannot tell you how many times, either writing for the Connecticut Supreme Court or joining my colleagues in one of their opinions, we concluded matters based on the jurisprudential concept of standing relying on well settled principles and precedent, often highlighting United States Supreme Court authority
8 minute read
June 14, 2024 | Litigation Daily

Litigators of the Week Runners-Up

Kirkland & Ellis scored a knockout win for Sun Pharmaceutical Industries Ltd. in a more than decadelong multidistrict litigation where the company was accused of conspiring to delay the launch of a generic version of the blockbuster cholesterol drug Lipitor.
7 minute read
June 12, 2024 | Law.com

Missouri Appellate Court Affirms $800K Judgment Against Psychiatrist for Vyvanse-Induced Stroke

"All of that said, even if F.D.'s differential diagnosis was thus unreliable and should not have been admitted, other substantial evidence at trial tended to prove that K.P.'s death was caused by Vyvanse use. This Court will not reverse a judgment unless the circuit court's error in admitting expert testimony 'materially affected the merits of the action,'" Missouri Court of Appeals Judge Cristian M. Stevens.
5 minute read
June 11, 2024 | The Recorder

43 States Reach $700 Million Settlement With J&J in Talc Product Lawsuits

A $700 million settlement reached by Johnson & Johnson with attorneys general from 43 states prohibits the pharmaceutical company from manufacturing, selling or distributing its talcum-based body powder products, which are known to increase the risk for cancer, in the United States.
4 minute read
Law Journal Press | Digital Book Connecticut Medical Malpractice: A Manual of Practice and Procedure, 7th Edition Authors: Joyce A. Lagnese, Calum B. Anderson, Frank H. Santoro View this Book

View more book results for the query "US Food and Drug Administration"

June 11, 2024 | New Jersey Law Journal

'We Just Focused on the Factual Record': Kirkland & Ellis Successfully Defends Pharmaceutical Companies in Lipitor MDL

Counsel for Sun Pharmaceutical and Ranbaxy, Devora W. Allon, a partner with Kirkland & Ellis in New York, said that the plaintiffs hired a regulatory expert to say that the Food and Drug Administration moves as fast as it can and that if there had been an earlier target date, the FDA would have met that date.
6 minute read
June 11, 2024 | Daily Report Online

Election Pits Gwinnett Judge Regina Matthews Against Lawyer Tuwanda Rush Williams

Voters to decide between Gwinnett County Magistrate Judge Regina Matthews and Thompson O'Brien Kappler & Nasuti of counsel Tuwanda Rush Williams during June 18 runoff election.
14 minute read
June 05, 2024 | Daily Report Online

McDermott Taps King & Spalding Lawyer to Grow White-Collar Group in Atlanta

Amy Bentsen (Boring) is the firm's first white-collar criminal defense and investigations partner to be based in McDermott's 4-year-old Atlanta office.
4 minute read
June 04, 2024 | National Law Journal

Novo Nordisk Files Multiple Complaints Alleging Trademark Infringement, False Advertising

"We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded 'semaglutide' products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines," said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.
4 minute read
June 04, 2024 | Law.com

Novo Nordisk Files Multiple Complaints Alleging Trademark Infringement, False Advertising Across U.S.

"We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded 'semaglutide' products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines," said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.
4 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Will Generative AIs Transform Legal Services? Defensibility and Security Must Be a Focus

    Brought to you by HaystackID

    Download Now

  • Unlocking the Power of Early Case Assessment Workflows

    Brought to you by Integreon

    Download Now

  • Good Legal Technology is Good Business: A Case for Bringing Employment Issues In-House

    Brought to you by LexisNexis®

    Download Now

  • Insights and Strategies for Effective Succession Planning in AM Law 100 Firms

    Brought to you by Gallagher

    Download Now

NEXT